Unleashing TNF Cytotoxicity to Enhance Cancer Immunotherapy

A spate of recent studies investigating tumor immune evasion through the application of CRISPR-based gene-editing screens have highlighted tumor necrosis factor (TNF)-mediated killing as an important component of the mammalian T cell antitumor repertoire.